High reprint orders in medical journals and pharmaceutical industry funding: Case-control study

BMJ (Online)

Volumn 345, Issue 7864, 2012, Pages

  Handel, Adam E ^a,b   Patel, Sunil V ^c,d   Pakpoor, Julia ^a,b   Ebers, George C ^a,b   Goldacre, Ben ^c   Ramagopalan, Sreeram V ^c,e,f  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^d LONDON HEALTH SCIENCES CENTRE   (Canada)

^e UNIVERSITY OF OXFORD   (United Kingdom)

^f QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CASE CONTROL STUDY; DRUG INDUSTRY; FUNDING; HEALTH CARE POLICY; MEDICAL LITERATURE; PRINTING; PRIORITY JOURNAL; PUBLICATION; PUBLISHING;

EID: 84863593744     PISSN: None     EISSN: 17561833     Source Type: Journal    
DOI: 10.1136/bmj.e4212     Document Type: Article

References (5)

1. Vinson DC. Reprint requests for family medicine literature: how do we respond? Fam Med 1990;22:404-5. (Pubitemid 20317518)
2. Stryer D, Bero LA. Characteristics of materials distributed by drug companies. An evaluation of appropriateness. J Gen Intern Med 1996;11:575-83. (Pubitemid 26403757)
3. Smith R. Medical journals are an extension of the marketing arm of pharmaceutical companies. PLoS Med 2005;2:e138.
4. Jefferson T, Di Pietrantonj C, Debalini MG, Rivetti A, Demicheli V. Relation of study quality, concordance, take home message, funding, and impact in studies of influenza vaccines: systematic review. BMJ 2009;338:b354.
5. Hopewell S, Clarke M. How important is the size of a reprint order? Int J Technol Assess Health Care 2003;19:711-4. (Pubitemid 38405644)